Bora Pharmaceuticals Co Ltd 6472
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 6472 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- TWD 753.00
- Day Range
- TWD 731.00–805.00
- 52-Week Range
- TWD 534.30–845.00
- Bid/Ask
- TWD 799.00 / TWD 800.00
- Market Cap
- TWD 80.54 Bil
- Volume/Avg
- 6.5 Mil / 2.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 22.65
- Price/Sales
- 6.76
- Dividend Yield (Trailing)
- 0.77%
- Dividend Yield (Forward)
- 0.77%
- Total Yield
- 0.85%
Company Profile
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Commercial sales segment, Contract Development & Manufacturing Organization segment, and Other segment. The majority of revenue is derived from the Commercial sales segment. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 94
- Website
- https://www.bora-corp.com
Comparables
Valuation
|
Metric
|
6472
|
1701
|
4132
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.65 | 20.29 | — |
Price/Book Value | 9.31 | 0.90 | 10.26 |
Price/Sales | 6.76 | 0.76 | 65.10 |
Price/Cash Flow | 17.85 | 10.84 | — |
Price/Earnings
6472
1701
4132
Financial Strength
|
Metric
|
6472
|
1701
|
4132
|
|---|---|---|---|
Quick Ratio | 0.96 | 0.81 | 0.75 |
Current Ratio | 1.21 | 1.53 | 1.14 |
Interest Coverage | 23.61 | 7.42 | −53.99 |
Quick Ratio
6472
1701
4132
Profitability
|
Metric
|
6472
|
1701
|
4132
|
|---|---|---|---|
Return on Assets (Normalized) | 14.74% | 2.59% | −39.36% |
Return on Equity (Normalized) | 48.52% | 4.43% | −60.61% |
Return on Invested Capital (Normalized) | 23.74% | 3.44% | −41.37% |
Return on Assets
6472
1701
4132
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Yfqcbwvjjx | Rhfqs | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Qkdxvlfhcf | Vxtlw | $79.3 Bil | |
HLN
| Haleon PLC ADR | Jzpskcdh | Kwx | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Wfbcprygc | Rgjxj | $18.9 Bil | |
VTRS
| Viatris Inc | Dxtvlrhz | Bwxbl | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Gnjccprfm | Lcks | $11.7 Bil | |
CTLT
| Catalent Inc | Knyvpmzth | Gsthfl | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Yzllfgf | Cmxw | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Gxshwlbs | Gvt | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pqxvvdt | Qhfblw | $3.2 Bil |